ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

HOOK Company Profile and Key Details

NASDAQ : HOOK

HOOKIPA Pharma Inc.

$1.25

0.14+12.61%

At Close 4:00 PM

70.51

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

HOOK Stock Price Chart

Stock Price Today

HOOKIPA Pharma Inc. (HOOK) stock surged +12.61%, trading at $1.25 on NASDAQ, up from the previous close of $1.11. The stock opened at $1.15, fluctuating between $1.15 and $1.28 in the recent session.

Stock Snapshot

1.11

Prev. Close

1.15

Open

15.07M

Market Cap

12.06M

Number of Shares

1.15

Day Low

1.28

Day High

-0.36

P/E Ratio

71.26%

Free Float in %

-3.47

EPS (TTM)

0.91

Book Value

-0.62

Cash Flow per Share

50.47K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 12, 2025	1.15	1.28	1.15	1.25	51.31K
Mar 11, 2025	1.17	1.18	1.11	1.11	105.76K
Mar 10, 2025	1.24	1.30	1.20	1.20	75.5K
Mar 07, 2025	1.29	1.30	1.27	1.27	22.35K
Mar 06, 2025	1.34	1.34	1.25	1.30	122.95K
Mar 05, 2025	1.38	1.46	1.34	1.34	22.41K
Mar 04, 2025	1.37	1.42	1.34	1.39	85.3K
Mar 03, 2025	1.51	1.59	1.41	1.41	67.91K
Feb 28, 2025	1.48	1.57	1.45	1.53	50.44K
Feb 27, 2025	1.49	1.69	1.49	1.50	42.91K
Feb 26, 2025	1.62	1.69	1.49	1.51	216.1K
Feb 25, 2025	1.72	1.81	1.55	1.63	154.66K
Feb 24, 2025	1.75	1.88	1.74	1.76	31.1K
Feb 21, 2025	1.80	1.91	1.77	1.78	38.1K
Feb 20, 2025	1.79	1.87	1.77	1.81	37.9K
Feb 19, 2025	1.83	1.90	1.78	1.79	47.51K
Feb 18, 2025	1.90	1.95	1.85	1.88	31.62K
Feb 14, 2025	1.88	1.95	1.84	1.89	47.71K
Feb 13, 2025	1.89	1.96	1.81	1.90	18.92K
Feb 12, 2025	1.69	1.92	1.65	1.89	66.28K

Contact Details

New York, NY 10118

United States

Website: https://www.hookipapharma.comContact: 431 890 6360

About Company

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current HOOKIPA Pharma Inc. (HOOK) stock price?

HOOKIPA Pharma Inc. (NASDAQ: HOOK) stock price is $1.25 in the last trading session. During the trading session, HOOK stock reached the peak price of $1.28 while $1.15 was the lowest point it dropped to. The percentage change in HOOK stock occurred in the recent session was 12.61% while the dollar amount for the price change in HOOK stock was $0.14.

HOOK's industry and sector of operation?

The NASDAQ listed HOOK is part of Biotechnology industry that operates in the broader Healthcare sector. HOOKIPA Pharma Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HOOK?

Mr. Andreas Bergthaler
Co-Founder
Mr. Jorn Aldag
Chief Executive Officer & Director
Mr. Joern Aldag
Chief Executive Officer & Director
Prof. Rolf M. Zinkernagel M.D., Ph.D.
Co-Founder
Dr. Roman Necina Ph.D.
Chief Devel. Officer
Dr. Reinhard Kandera Ph.D.
Chief Financial Officer & Director
Mr. Michael Szumera
Executive Director of Communications
Ms. Christine D. Baker M.B.A.
Chief Operating Officer
Ms. Marine Popoff
Communications & Investor Relations Mang.
Dr. Klaus Orlinger Ph.D.
Chief Scientific Officer
Mr. Lukas Flatz
Co-Founder
Mr. Matthew L. S. Beck
Executive Director of Investor Relations

How HOOK did perform over past 52-week?

HOOK's closing price is 12.61% higher than its 52-week low of $1.11 where as its distance from 52-week high of $10.50 is -88.09%.

How many employees does HOOK have?

Number of HOOK employees currently stands at 151.

Link for HOOK official website?

Official Website of HOOK is: https://www.hookipapharma.com

How do I contact HOOK?

HOOK could be contacted at phone 431 890 6360 and can also be accessed through its website. HOOK operates from 350 Fifth Avenue, New York, NY 10118, United States.

How many shares of HOOK are traded daily?

HOOK stock volume for the day was 50.47K shares. The average number of HOOK shares traded daily for last 3 months was 130.05K.

What is the market cap of HOOK currently?

The market value of HOOK currently stands at $15.07M with its latest stock price at $1.25 and 12.06M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	151
Beta	0.7
Sales or Revenue	$20.13M
5Y Sales Change%	3.556%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology